Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Check out the new look and feel of Harvard Catalyst Profiles! Learn more on our About and Help pages.

Victor H. Gerbaudo

Title
Institution
Department
Address
Phone
Fax
Profile Picture

Biography
BS, Health Sciences1984
PhD, Biological / Biomedical Sciences1992
Post-doctoral training, Nuclear Medicine 1994
Post-doctoral training, Nuclear Oncology 2000
MS, Health Care Administration2012
2000
Madame Curie Radiologic Science Lecturer
2001
Partners in Excellence Award in Leadership and Innovation
2003
Radiology Department Team Award
2004
Award of Merit, American Roentgen Ray Society
2004
One of 3 Best Papers of the Year Award, SNM
2007
Partners in Excellence Team Award: Cyclotron Project
2008
Partners in Excellence Team Award: Shapiro Cardiovascular Center Working Group
2008
Partners in Excellence Team Award: Electronic Signature Project
2012
Cum Laude Award, Radiological Society of North America
2013
One of 3 Best Papers of the Year Award, SNM
2014
Opening Plenary Speaker, World Federation of Nuclear Medicine & Biology Congress

Overview
Dr. Gerbaudo is the Senior Director of Nuclear Medicine, Molecular Imaging and Non-invasive Cardiovascular Imaging, and Director of Clinical Integration in the Department of Radiology at Brigham and Women's Hospital. He is a clinical Nuclear Oncology scientist with more than 20 years of experience in the field. His clinical, teaching and research efforts focus on the in-vivo qualitative and quantitative monitoring of tumor biology, imaging, and response to therapy with PET/CT.

Specific Academic Interests:

- Molecular biomarkers as predictors of clinical outcome in cancer patients
- Correlation between molecular biomarkers and medical imaging signatures
- PET Imaging-based phenotyping of thoracic malignancies
- Molecular imaging as a biomarker to non-invasively direct and monitor response to cancer therapy

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Shyn PB, Casadaban LC, Sainani NI, Sadow CA, Bunch PM, Levesque VM, Kim CK, Gerbaudo VH, Silverman SG. Intraprocedural Ablation Margin Assessment by Using Ammonia Perfusion PET during FDG PET/CT-guided Liver Tumor Ablation: A Pilot Study. Radiology. 2018 Jul; 288(1):138-145. PMID: 29613843.
    View in: PubMed
  2. Gerbaudo VH, Killoran JH, Kim CK, Hornick JL, Nowak JA, Enzinger PC, Mamon HJ. Pilot study of serial FLT and FDG-PET/CT imaging to monitor response to neoadjuvant chemoradiotherapy of esophageal adenocarcinoma: correlation with histopathologic response. Ann Nucl Med. 2018 Apr; 32(3):165-174. PMID: 29332233.
    View in: PubMed
  3. Zukotynski K, Gerbaudo VH, Kim CK. SPECT/CT in Neoplastic Disease. In Kim CK and Zukotynski K CK, editors. SPECT and SPECT/CT: a clinical guide. Thieme Publishers. 2017.
  4. Gerbaudo VH, Kim CK. PET Imaging-Based Phenotyping as a Predictive Biomarker of Response to Tyrosine Kinase Inhibitor Therapy in Non-small Cell Lung Cancer: Are We There Yet? Nucl Med Mol Imaging. 2017 Mar; 51(1):3-10. PMID: 28250852.
    View in: PubMed
  5. Zukotynski KA, Gerbaudo VH. Molecular Imaging and Precision Medicine in Lung Cancer. PET Clin. 2017 Jan; 12(1):53-62. PMID: 27863566.
    View in: PubMed
  6. Gerbaudo VH, Garcia CA . PET/CT of Lung Cancer. In Schoepf UJ & Meinel F. Multidetector-Row CT of the Thorax, 2nd ed. Springer International. 2016.
  7. Shim H, Joo J, Choi HJ, Hyun H, Gerbaudo VH, Kim CK. Lack of Increased FDG Uptake in the Lacrimal and Salivary Glands in Patients With Sarcoidosis and Potential Underlying Mechanism. Clin Nucl Med. 2016 Apr; 41(4):274-7. PMID: 26825201.
    View in: PubMed
  8. Choi HJ, Shim H, Hyun H, Gerbaudo VH, Kim CK. FDG PET/CT Appearance of Radiation Nephritis. Clin Nucl Med. 2016 Mar; 41(3):253-4. PMID: 26562578.
    View in: PubMed
  9. Barbone D, Follo C, Echeverry N, Gerbaudo VH, Klabatsa A, Bueno R, Felley-Bosco E, Broaddus VC. Autophagy Correlates with the Therapeutic Responsiveness of Malignant Pleural Mesothelioma in 3D Models. PLoS One. 2015; 10(8):e0134825. PMID: 26284517; PMCID: PMC4540424.
  10. Zukotynski KA, Kim CK, Gerbaudo VH, Hainer J, Taplin ME, Kantoff P, den Abbeele AD, Seltzer S, Sweeney CJ. (18)F-FDG-PET/CT and (18)F-NaF-PET/CT in men with castrate-resistant prostate cancer. Am J Nucl Med Mol Imaging. 2015; 5(1):72-82. PMID: 25625029; PMCID: PMC4299771.
  11. Horky LL, Gerbaudo VH, Zaitsev A, Plesniak W, Hainer J, Govindarajulu U, Kikinis R, Dietrich J. Systemic chemotherapy decreases brain glucose metabolism. Ann Clin Transl Neurol. 2014 Oct; 1(10):788-98. PMID: 25493270; PMCID: PMC4241806.
  12. Araki T, Sholl LM, Gerbaudo VH, Hatabu H, Nishino M. Thymic measurements in pathologically proven normal thymus and thymic hyperplasia: intraobserver and interobserver variabilities. Acad Radiol. 2014 Jun; 21(6):733-42. PMID: 24809315; PMCID: PMC4022310.
  13. Park M, Gerbaudo V, Hamberg L, Seaver K, Kijewski M. SU-D-9A-04: Brain PET/CT Imaging On a Scanner with a Large Axial Field-Of-View. Med Phys. 2014 Jun; 41(6):122-123. PMID: 28037596.
    View in: PubMed
  14. Sun Y, Gu X, Zhang E, Park MA, Pereira AM, Wang S, Morrison T, Li C, Blenis J, Gerbaudo VH, Henske EP, Yu JJ. Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells. Cell Death Dis. 2014 May 15; 5:e1231. PMID: 24832603; PMCID: PMC4047866.
  15. Araki T, Sholl LM, Gerbaudo VH, Hatabu H, Nishino M. Intrathymic cyst: clinical and radiological features in surgically resected cases. Clin Radiol. 2014 Jul; 69(7):732-8. PMID: 24824976; PMCID: PMC4068340.
  16. Araki T, Sholl LM, Gerbaudo VH, Hatabu H, Nishino M. Imaging characteristics of pathologically proven thymic hyperplasia: identifying features that can differentiate true from lymphoid hyperplasia. AJR Am J Roentgenol. 2014 Mar; 202(3):471-8. PMID: 24555583; PMCID: PMC4020512.
  17. Wachsmann JW, Gerbaudo VH. Thorax: normal and benign pathologic patterns in FDG-PET/CT imaging. PET Clin. 2014 Apr; 9(2):147-68. PMID: 25030279.
    View in: PubMed
  18. Cervo M, Gerbaudo VH, Park MA, Moore SC. Quantitative simultaneous 111In/99mTc SPECT-CT of osteomyelitis. Med Phys. 2013 Aug; 40(8):082501. PMID: 23927346; PMCID: PMC3716783.
  19. Wada K, Gerbaudo VH, Spector M. Effects of PDGF-BB and OP-1 on mesenchymal stem cells in a porous mineral block. Int J Periodontics Restorative Dent. 2013 Mar-Apr; 33(2):e72-8. PMID: 23484183.
    View in: PubMed
  20. Etchebehere E, Gerbaudo VH, Nuñez R, Obando A, Paez D, Sen I. . Guide on Clinical Standard Operating Procedures on the use of PET/CT: A Practical Approach for Use in Adult Oncology. International Atomic Energy Agency, Department of Nuclear Sciences and Applications, Division of Human Health, Nuclear Medicine Section; http://www-pub.iaea.org/MTCD/Publications/PDF/Pub1616_web.pdf . 2013.
  21. Gerbaudo VH . Mesotelioma Maligno. In Soriano Castrejon A, Comin M & Garcia Vicente AM, editors. Medicina Nuclear en la Práctica Clínica, 2nd edition,. 2012.
  22. Schleipman AR, Gerbaudo VH. Occupational radiation dosimetry assessment using an automated infusion device for positron-emitting radiotracers. J Nucl Med Technol. 2012 Dec; 40(4):244-8. PMID: 23024340.
    View in: PubMed
  23. Donohoe KJ, Agrawal G, Frey KA, Gerbaudo VH, Mariani G, Nagel JS, Shulkin BL, Stabin MG, Stokes MK. SNM practice guideline for brain death scintigraphy 2.0. J Nucl Med Technol. 2012 Sep; 40(3):198-203. PMID: 22743146.
    View in: PubMed
  24. Ikuta I, Sodickson A, Wasser EJ, Warden GI, Gerbaudo VH, Khorasani R. Exposing exposure: enhancing patient safety through automated data mining of nuclear medicine reports for quality assurance and organ dose monitoring. Radiology. 2012 Aug; 264(2):406-13. PMID: 22627599; PMCID: PMC3401350.
  25. Gill RR, Richards WG, Yeap BY, Matsuoka S, Wolf AS, Gerbaudo VH, Bueno R, Sugarbaker DJ, Hatabu H. Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume. AJR Am J Roentgenol. 2012 Feb; 198(2):359-63. PMID: 22268178.
    View in: PubMed
  26. Tatli, S, Gerbaudo VH, Silverman S. PET/CT Guided Interventions. In Gerbaudo VH , editor. A Case-Based Approach to PET/CT in Oncology. Cambridge University Press. 2012.
  27. Gerbaudo VH. Lung and Pleural Malignancies. In: Gerbaudo VH, editor. A Case-Based Approach to PET/CT in Oncology. Cambridge University Press. 2012.
  28. Gerbaudo VH & Gill, R. Esophageal Cancer. In Gerbaudo VH , editor. A Case-Based Approach to PET/CT in Oncology. Cambridge University Press. 2012.
  29. Gerbaudo VH, Editor. A Case-Based Approach to PET/CT in Oncology. Cambridge University Press. 2012.
  30. Britz-Cunningham S, & Gerbaudo VH. Functional Anatomy of the FDG Image. In: Gerbaudo VH, editor. A Case-Based Approach to PET/CT in Oncology. Cambridge University Press. 2012.
  31. Killoran JH, Gerbaudo VH, Mamede M, Ionascu D, Park SJ, Berbeco R. Motion artifacts occurring at the lung/diaphragm interface using 4D CT attenuation correction of 4D PET scans. J Appl Clin Med Phys. 2011 Nov 15; 12(4):3502. PMID: 22089005.
    View in: PubMed
  32. Nowak AK, Francis RJ, Katz SI, Gerbaudo VH. A Multimodality Imaging Review of Malignant Pleural Mesothelioma Response Assessment. PET Clin. 2011 Jul; 6(3):299-311. PMID: 27156725.
    View in: PubMed
  33. Gerbaudo VH, Katz SI, Nowak AK, Francis RJ. Multimodality Imaging Review of Malignant Pleural Mesothelioma Diagnosis and Staging. PET Clin. 2011 Jul; 6(3):275-97. PMID: 27156724.
    View in: PubMed
  34. Tatli S, Gerbaudo VH, Feeley CM, Shyn PB, Tuncali K, Silverman SG. PET/CT-guided percutaneous biopsy of abdominal masses: initial experience. J Vasc Interv Radiol. 2011 Apr; 22(4):507-14. PMID: 21367619.
    View in: PubMed
  35. Gerbaudo VH, Mamede M, Trotman-Dickenson B, Hatabu H, Sugarbaker DJ. FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival. Eur J Nucl Med Mol Imaging. 2011 May; 38(5):810-21. PMID: 21210110.
    View in: PubMed
  36. Gerbaudo VH and Jacobson F. PET/CT of Lung Cancer. In Van Den Abbeele, A.D. & Donahue K. Teaching Atlas of Nuclear Medicine. 2nd ed . Thieme Publishers. 2011.
  37. Horky LL, Hsiao EM, Weiss SE, Drappatz J, Gerbaudo VH. Dual phase FDG-PET imaging of brain metastases provides superior assessment of recurrence versus post-treatment necrosis. J Neurooncol. 2011 May; 103(1):137-46. PMID: 20838854.
    View in: PubMed
  38. Tatli S, Gerbaudo VH, Mamede M, Tuncali K, Shyn PB, Silverman SG. Abdominal masses sampled at PET/CT-guided percutaneous biopsy: initial experience with registration of prior PET/CT images. Radiology. 2010 Jul; 256(1):305-11. PMID: 20574103.
    View in: PubMed
  39. Gerbaudo VH, Britz-Cunningham S. Primary lesions were more 18F-FDG avid in patients with distant spread than in those without extensive disease. Mol Imaging Biol. 2009 Nov-Dec; 11(6):487; author reply 488. PMID: 19845044.
    View in: PubMed
  40. Schleipman AR, Gallagher PW, Gerbaudo VH. Optimizing safety of selective internal radiation therapy (SIRT) of hepatic tumors with 90Y resin microspheres: a systematic approach to preparation and radiometric procedures. Health Phys. 2009 Feb; 96(2 Suppl):S16-21. PMID: 19125051.
    View in: PubMed
  41. Gill RR, Gerbaudo VH, Sugarbaker DJ, Hatabu H. Current trends in radiologic management of malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 2009; 21(2):111-20. PMID: 19822282.
    View in: PubMed
  42. Britz-Cunningham SH, Millstine JW, Gerbaudo VH. Improved discrimination of benign and malignant lesions on FDG PET/CT, using comparative activity ratios to brain, basal ganglia, or cerebellum. Clin Nucl Med. 2008 Oct; 33(10):681-7. PMID: 18806567.
    View in: PubMed
  43. Park SJ, Ionascu D, Killoran J, Mamede M, Gerbaudo VH, Chin L, Berbeco R. Evaluation of the combined effects of target size, respiratory motion and background activity on 3D and 4D PET/CT images. Phys Med Biol. 2008 Jul 07; 53(13):3661-79. PMID: 18562782.
    View in: PubMed
  44. Gill RR, Gerbaudo VH, Jacobson FL, Trotman-Dickenson B, Matsuoka S, Hunsaker A, Sugarbaker DJ, Hatabu H. MR imaging of benign and malignant pleural disease. Magn Reson Imaging Clin N Am. 2008 May; 16(2):319-39, x. PMID: 18474335.
    View in: PubMed
  45. Mamede M, El Fakhri G, Abreu-e-Lima P, Gandler W, Nosé V, Gerbaudo VH. Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmation. Ann Nucl Med. 2007 Dec; 21(10):553-62. PMID: 18092131.
    View in: PubMed
  46. Zhu X, Park MA, Gerbaudo VH, Moore SC. Quantitative simultaneous In-111/Tc-99m planar imaging in a long-bone infection phantom. Phys Med Biol. 2007 Dec 21; 52(24):7353-65. PMID: 18065843.
    View in: PubMed
  47. Yamamuro M, Gerbaudo VH, Gill RR, Jacobson FL, Sugarbaker DJ, Hatabu H. Morphologic and functional imaging of malignant pleural mesothelioma. Eur J Radiol. 2007 Dec; 64(3):356-66. PMID: 17954021.
    View in: PubMed
  48. Gerbaudo VH, Julius B. Anatomo-metabolic characteristics of atelectasis in F-18 FDG-PET/CT imaging. Eur J Radiol. 2007 Dec; 64(3):401-5. PMID: 17870274.
    View in: PubMed
  49. Mamede M, Abreu-E-Lima P, Oliva MR, Nosé V, Mamon H, Gerbaudo VH. FDG-PET/CT tumor segmentation-derived indices of metabolic activity to assess response to neoadjuvant therapy and progression-free survival in esophageal cancer: correlation with histopathology results. Am J Clin Oncol. 2007 Aug; 30(4):377-88. PMID: 17762438.
    View in: PubMed
  50. Parysow O, Mollerach AM, Jager V, Racioppi S, San Roman J, Gerbaudo VH. Low-dose oral propranolol could reduce brown adipose tissue F-18 FDG uptake in patients undergoing PET scans. Clin Nucl Med. 2007 May; 32(5):351-7. PMID: 17452860.
    View in: PubMed
  51. Gerbaudo VH. Functional Anatomy of Tumor Aggressiveness in Lung Cancer and Malignant Pleural Mesothelioma. Molecular Imaging and Biology. 2005; 7:86.
  52. Wang H, Gerbaudo VH, Hobbs LW, Spector M. Quantitation of osteoblast-like cell mineralization on tissue culture polystyrene and Ti-6Al-4V alloy disks by Tc-99m-MDP labeling and imaging in vitro. Bone. 2005 Jan; 36(1):84-92. PMID: 15664006.
    View in: PubMed
  53. Schleipman AR, Gerbaudo VH, Castronovo FP. Radiation disaster response: preparation and simulation experience at an academic medical center. J Nucl Med Technol. 2004 Mar; 32(1):22-7. PMID: 14990671.
    View in: PubMed
  54. Rajadhyaksha CD, Parker JA, Barbaras L, Gerbaudo VH. Normal and Benign Pathologic Findings in 18-FDG-PET and PET/CT. Harvard Medical School Joint Program in Nuclear Medicine. 2004.
  55. Moore, SC, Park M, El Fakhri G, Gerbaudo VH, Zimmerman RE. A General-Spectral Method for Improved Quantitative SPECT Imaging of In-111. Nuclear Science Symposium Conference Record, IEEE. 2004; 6:3682-3684.
  56. Gerbaudo VH, Britz-Cunningham S, Sugarbaker DJ, Treves ST. Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma. Thorax. 2003 Dec; 58(12):1077-82. PMID: 14645979; PMCID: PMC1746546.
  57. Gerbaudo VH. 18F-FDG imaging of malignant pleural mesothelioma: scientiam impendere vero... Nucl Med Commun. 2003 Jun; 24(6):609-14. PMID: 12766595.
    View in: PubMed
  58. Donohoe KJ, Frey KA, Gerbaudo VH, Mariani G, Nagel JS, Shulkin B. Procedure guideline for brain death scintigraphy. J Nucl Med. 2003 May; 44(5):846-51. PMID: 12732688.
    View in: PubMed
  59. Gerbaudo VH, Sugarbaker DJ, Britz-Cunningham S, Di Carli MF, Mauceri C, Treves ST. Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology. J Nucl Med. 2002 Sep; 43(9):1144-9. PMID: 12215551.
    View in: PubMed
  60. Di Carli MF, Gerbaudo VH, Singh TP, Treves ST. Cardiopulmonary Studies in Pediatric Nuclear Medicine . In: Sandler MP, Coleman RE and Patton JA, editors. Diagnostic Nuclear Medicine . 2002.
  61. Di Carli M, Czernin J, Hoh CK, Gerbaudo VH, Brunken RC, Huang SC, Phelps ME, Schelbert HR. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation. 1995 Apr 01; 91(7):1944-51. PMID: 7895351.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Gerbaudo's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (247)
Explore
_
Co-Authors (44)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_